Facing tens of thousands of lawsuits over cancer risks on the popular heartburn drug Zantac, GSK has argued | Facing tens of thousands of lawsuits over cancer risks on the popular heartburn drug Zantac, GSK has argued there's "no consistent or reliable evidence" that the medicine causes any cancer. But a new report in Bloomberg Businessweek says GSK's own scientists have long known about the risks.
Pretty much